NCT03385356View on ClinicalTrials.gov

Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

April 30, 2018

Study Completion Date

April 30, 2018

Conditions
Multiple Sclerosis, Relapsing-RemittingVitamin D Deficiency
Interventions
DRUG

Vitamin D

Vitamin D supplementation of 1000IU vs 4000IU vitamin D per day for four months during winter time, when levels of vitamin D in serum of MS patients are especially low.

Trial Locations (1)

2000

University Medical Centre Maribor, Maribor

All Listed Sponsors
collaborator

Medical Faculty Maribor

UNKNOWN

lead

University Medical Centre Maribor

OTHER

NCT03385356 - Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis | Biotech Hunter | Biotech Hunter